EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential Drug-Drug Interactions With Nirmatrelvir/Ritonavir Among Long-Term Care Facility Residents

Marzan A Khan, Lori A Daiello, Sarah D Berry, Daniel A Harris, Hemalkumar B Mehta, Yu-Chia Sam Hsu, Charles E Leonard, Kevin W McConeghy, Andrew R Zullo

Journal of the American Medical Directors Association · 2026

DOI: 10.1016/j.jamda.2026.106365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Directors Association, 2026. Verfasst von Marzan A Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA; Center for Gerontology and Healthcare Research, Brown Univ…. Hauptthemen laut MEDLINE: Ritonavir, COVID-19 Drug Treatment. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitonavirCOVID-19 Drug TreatmentHumansDrug InteractionsFemaleMaleNursing Home ResidentsUnited StatesAged, 80 and overAgedLong-Term CareCohort Studies

Stichwörter der Autor:innen

COVID-19drug-drug interactionlong-term care facility residentsnirmatrelvir/ritonavir

Substanzen

Ritonavir

Autor:innen und Institutionen

  • Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA; Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI, USA. Electronic addres…
  • Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI, USA; Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA.
  • Hinda and Arthur Marcus Institute for Aging Research and Department of Medicine, Hebrew Senior Life, Boston, MA, USA.
  • Department of Epidemiology, College of Health Sciences, University of Delaware, Newark, DE, USA.
  • Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Biostatistics, Epidemiology, and Informatics, Perelman School…

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Khan, M. A., Daiello, L. A., Berry, S. D., Harris, D. A., Mehta, H. B., Hsu, Y. S., Leonard, C. E., McConeghy, K. W., & Zullo, A. R. (2026). Potential Drug-Drug Interactions With Nirmatrelvir/Ritonavir Among Long-Term Care Facility Residents. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2026.106365

Vancouver

Khan MA, Daiello LA, Berry SD, Harris DA, Mehta HB, Hsu YS, et al. Potential Drug-Drug Interactions With Nirmatrelvir/Ritonavir Among Long-Term Care Facility Residents. Journal of the American Medical Directors Association. 2026. doi:10.1016/j.jamda.2026.106365

BibTeX
@article{Khan2026,
  author = {Khan, Marzan A and Daiello, Lori A and Berry, Sarah D and Harris, Daniel A and Mehta, Hemalkumar B and Hsu, Yu-Chia Sam and Leonard, Charles E and McConeghy, Kevin W and Zullo, Andrew R},
  title = {Potential Drug-Drug Interactions With Nirmatrelvir/Ritonavir Among Long-Term Care Facility Residents},
  journal = {Journal of the American Medical Directors Association},
  year = {2026},
  doi = {10.1016/j.jamda.2026.106365}
}
Kostenlos starten →